CHI Logo
Shop
Checkout
Header Graphic
September 10, 2010
| Insight Pharma Reports > All Reports
ALL REPORTS

Loading...

Corporate Subscription Program

Insight Pharma Reports has developed and maintained a very impressive and loyal client base, including senior level executives, global competitive intelligence executives, librarians, information specialists, and research scientists.

Click here for more info
Add to Del.icio.us Add to digg Add to Connotea Add to Facebook Add to LinkedIn EMail Page Printer Friendly Book Mark

2006 Reports:

Loading...

The following reports are published and available for immediate shipment.

 

Please contact Al Doig at adoig@healthtech.com to suggest topics to be updated or new topics to be covered in the area of pharmaceutical drug discovery and development.

Outlook for Predictive Safety Technologies
Outlook for Predictive Safety Technologies
November 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cancer Immunotherapies and Vaccines: Pipeline Analysis and Competitive Dynamics
Cancer Immunotherapies and Vaccines: Pipeline Analysis and Competitive Dynamics
November 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Specialty Pharmaceuticals: Driving Industry Growth into the Next Decade
Specialty Pharmaceuticals: Driving Industry Growth into the Next Decade
October 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Potential Breakthroughs in Neurotherapeutics: Alzheimer's Disease, Parkinson's Disease, Depression, Bipolar Disorder, and Schizophrenia
Potential Breakthroughs in Neurotherapeutics: Alzheimer's Disease, Parkinson's Disease, Depression, Bipolar Disorder, and Schizophrenia
October 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Infectious Diseases: R&D Challenges and Market Drivers
Infectious Diseases: R&D Challenges and Market Drivers
September 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Comparative Genomic Hybridization: Current State and Future Directions
Comparative Genomic Hybridization: Current State and Future Directions
September 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary
Proteomics: Current State and Future Directions
Proteomics: Current State and Future Directions
September 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary
Antiviral Therapeutics: Pipelines and Competitive Dynamics
Antiviral Therapeutics: Pipelines and Competitive Dynamics
July 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD
Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD
June 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Microdosing in Translational Medicine: Pros and Cons
Microdosing in Translational Medicine: Pros and Cons
May 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Kinase Therapeutics: A Wealth of Targets Sparks a Highly Active Market
Kinase Therapeutics: A Wealth of Targets Sparks a Highly Active Market
May 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

The Impact of Genomics on Clinical Trials and Medical Practice
The Impact of Genomics on Clinical Trials and Medical Practice
April 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Multiplex Assays: Technologies, Applications, and Markets
Multiplex Assays: Technologies, Applications, and Markets
April 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Oncogenomics: The Future of Cancer Cure
Oncogenomics: The Future of Cancer Cure
January 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

2005 Reports
RNAi Therapeutics: Challenges in Drug Development and Delivery
November 2005
A New Paradigm for Clinical Development: The Clinical Trial in 2015
November 2005
Molecular Diagnostics: New Growth, New Markets
November 2005
Pharmaceutical R&D Productivity: The Path to Innovation
October 2005
Hematological Cancer Therapeutics: Pipelines and Competition
October 2005
Cancer Diagnostics: Technology and Business Trends
October 2005
Combination Therapies: Benefits and Challenges in Drug, Device, and Biologicals Development
August 2005
Powering Discovery through Target Evaluation: Moving Beyond the Validation Paradigm
August 2005
Pharmacodiagnostics: Technologies: Technologies, Competition, and Market Models
July 2005
Nutrigenomics: Impacts on Markets
June 2005
Inflammatory Disease Therapeutics: Pipelines
June 2005
Cardiovascular Diagnostics: Key Developments in Technologies and Markets
May 2005
Biomarkers in Clinical Development: Implications for Personalized Medicine and Streamlining R&D
March 2005
Neurogenomics and Neurotherapeutic Strategies: New Directions in Platforms, Targets, and Therapeutic Approaches
March 2005
2015: Strategic Considerations for the US Pharmaceutical Industry
February 2005
Metabolic Syndrome: Pipeline Analysis/Forecast
January 2005
All Reports 2010 - 2009 - 2008 - 2007 - 2006 - 2005

Cambridge Healthtech Institute

Footer Image
Loading...
  • 250 First Avenue, Suite 300
  • Needham MA 02494
  • phone: 781-972-5400
  • fax: 781-972-5425
  • chi@healthtech.com